[Atypical malignant hyperthermia. A higher incidence than expected].
Herrero
E
E
Casinello
F
F
de Stefano
J
J
Fernández-Guisasola
J
J
Pérez-Gallardo
A
A
D018685:Anesthetics, Inhalation / Q000009:adverse effects*; D002675:Child, Preschool; D005260:Female; D005483:Flushing / Q000139:chemically induced; D006221:Halothane / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008305:Malignant Hyperthermia / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D013030:Spain / Q000453:epidemiology; D013285:Strabismus / Q000601:surgery; D013390:Succinylcholine / Q000009:adverse effects*; D013610:Tachycardia / Q000139:chemically induced*
D018685:Anesthetics, Inhalation; D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine; D006221:Halothane